# The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

> **NCT02676466** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 289 (actual)

## Conditions studied

- Inflammation

## Interventions

- **DIETARY_SUPPLEMENT:** Omega-3 fish oil
- **DRUG:** Losartan
- **OTHER:** Corn Oil (Fish oil Placebo)
- **OTHER:** Cellulose Based (Losartan Placebo)

## Key facts

- **NCT ID:** NCT02676466
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-26
- **Primary completion:** 2018-06-22
- **Final completion:** 2018-06-22
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2024-05-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02676466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02676466, "The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02676466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*